Call us directly: NY: 1-631-893-3903 or NJ: 1-201-342-7662

Or visit one of our three locations: View Locations

Click here to see our five-star patient satisfaction reviews on Healthgrades

Oct 25

Brian Mehling, M.D. speaks at Tissue Engineering and Regenerative Medicine in Berlin

American orthopedic surgeon, internationally recognized stem cell researcher and founder of Mehling Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at the Fifth Annual Tissue Engineering and Regenerative Medicine. The conference was held September 12-14, 2016 in Berlin, Germany.
Dr. Mehling’s presentation was focused on stem cell therapy applications for arthritis and joint injuries.
“Stem cell therapies are, without a doubt, the future of medicine and we believe their role in treatments will become the preferred substitutes for many surgical, pharmacological, and rehabilitative medical services,” Dr. Mehling stated. “Our research studies designed to measure the safety and efficacy of intravenous, intra-articular, and intrathecal stem cell treatments. Our comprehensive stem cell protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and allogeneic human umbilical cord mesenchymal stem cells that treat various conditions such as spinal cord injury, traumatic brain injury, and chronic inflammation.”
Blue Horizon International is currently offering adipose-derived stem cell treatment for joint diseases at Malacky Hospital in Slovakia. Stem cells from adipose tissue can be easily obtained under local anesthesia. Stem cell therapy for arthritis and joint injures include the following steps: removal of adipose tissue under local anesthesia; processing of lipoaspirate, isolation of Stromal Vascular Fraction (SVF) and administration of preparation into the hip joint. In addition to mesenchymal stem cells, the cells isolated from adipose and connective tissues include other cells that: suppress the inflammatory response, contribute to the regeneration, create an optimal environment for receiving own stem cells, which prevent further degeneration of damaged tissues and cells in the new environment.
“We have treated more than 150 patients in Slovakia since opening our program, all with outstanding results. Stem cells are a great option when the patient is not a good candidate for traditional forms of treatment, such as invasive surgery or other treatment modalities,” said Doreen Santora, chief operating officer of Blue Horizon International.

About Mehling Orthopedics
Mehling Orthopedics performs complex orthopedic fracture surgeries, including high velocity fractures, open fractures and complex pelvic ring injuries as well as general orthopedic and sports medicine surgeries. Their team of experts delivers specialized care for orthopedic traumatic injuries. With all doctors certified by the American Board of Orthopedic Surgeons, they are committed to providing the finest medical care possible. For more information, please visit http://www.MehlingOrthopedics.com.

About Blue Horizon International
Blue Horizon International is a healthcare consulting company with a unique mission that combines treatment, research and philanthropic efforts. Across the globe quality care and services for medical treatments are provided along with resources needed to assist children and adults who are medically underserved. For more information, please visithttp://www.BlueHorizonInternational.com.

About BHI Therapeutic Sciences, LLC
BHI Therapeutic Sciences, LLC is currently offering cord blood, bone marrow and adipose stem cell derived treatments at Malacky Hospital in Slovakia and is fully licensed by the Ministry of Health of the Slovak Republic. For more information, please visithttp://www.BHIsciences.com